[Edaily Reporter Kwon Oh Seok ] LIG Nex1 Co., Ltd.(079550)’s stock price is surging in early trading. It appears that buying interest is surging on the back of positive outlooks from the securities industry. (Photo: LIG Defense&Aerospace) According to MP Doctor on the 10th, LIG Defense&Aerospace is trading at 810,000 won as of 9:16 a.m., up 9.58% from the previous trading day. Earlier today, SKSecurities released a report maintaining its “Buy” rating on LIG Defense&Aerospace and raising its target price from 1.15 million won to 1.3 million won. Han Seung-han, an analyst at SKSecurities, noted, “Second-quarter consolidated revenue was 1.1101 trillion won, and operating profit was 105.7 billion won, in line with market expectations (110.5 billion won),” adding, “The company achieved year-over-year profit growth driven by an expansion in the export share and overall business scale, without any significant one-time factors.” SKSecurities projected that while sales of the Cheongung system in the United Arab Emirates (UAE) totaled approximately 99 billion won in the second quarter, they would recover to a level of about 120 billion won in the second half of the year—similar to the fourth quarter of last year—resulting in annual Cheongung sales exceeding 500 billion won this year. Furthermore, the firm predicted that while its U.S. subsidiary, Ghost Robotics, will post an operating loss of 12 billion won in the second quarter—making a full-year loss this year inevitable—the deficit will narrow as the company is expected to reach the break-even point next year. One analyst stated, “Amid a global shortage of interceptor missiles, the capacity expansion at the Gumi and Gimcheon plants is not merely a preemptive investment but signifies progress in export contract negotiations and the securing of order visibility,” adding “Demand for air defense weapons in the Middle East is expanding due to the war in Iran, interest in the Cheongung-2 is growing among Southeast Asian countries such as Malaysia, Indonesia, and the Philippines, and the potential for future exports to Europe is expanding based on the memorandum of understanding (MOU) for a joint venture (JV) with Germany’s Rheinmetall,” the analyst added. He continued, “Explosive growth in volume (Q) and profitability (P) is expected to begin in earnest starting in 2028–2029,” and added, “We believe valuation concerns can be sufficiently alleviated at the current stock price level, so we are maintaining our ‘Top Pick’ rating for the defense sector.”
SHEIN, which shook up the global fast-fashion market with its $5 dresses, has seen its valuation shrink by nearly 100 trillion won in just four years. During the COVID-19 pandemic, SHEIN was hailed as…
D&D Pharmatech’s stock price plummeted after Pfizer halted development of MET-224o, an oral obesity treatment candidate acquired through its acquisition of Metsera. However, it has been confirmed that…
Min Ji-young, Olix Pharmaceuticals, Inc.’s New Executive Vice President and CDO. (Photo: Olix Pharmaceuticals, Inc.)
RNA interference (RNAi) therapeutics company Olix Pharmaceuticals, Inc.(226950)…